Home / Articles / Molecular foundations of COVID-19 pathogenesis

Molecular foundations of COVID-19 pathogenesis

Fedor Nikolaevich Novikov 1
Fedor Nikolaevich Novikov
, 
Viktor Sergeevich Stroylov 1
Viktor Sergeevich Stroylov
,  , 
Vladimir Evgenievich Nebolsin 3
Vladimir Evgenievich Nebolsin
1 N.D. Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences
2 National Research University "Higher School of Economics", Moscow
3 LLC «PHARMENTERPRISES», Moscow
Published 30 November 2019
16
Share
Cite this
GOST
 | 
Cite this
GOST
Novikov F. N. et al. Molecular foundations of COVID-19 pathogenesis // Russian Chemical Reviews. 2019. Vol. 89. No. 8. pp. 858-878.
GOST all authors (up to 50)
Novikov F. N., Stroylov V. S., Svitanko I., Nebolsin V. E. Molecular foundations of COVID-19 pathogenesis // Russian Chemical Reviews. 2019. Vol. 89. No. 8. pp. 858-878.
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.1070/RCR4961
UR - https://rcr.colab.ws/publications/10.1070/RCR4961
TI - Molecular foundations of COVID-19 pathogenesis
T2 - Russian Chemical Reviews
AU - Novikov, Fedor Nikolaevich
AU - Stroylov, Viktor Sergeevich
AU - Svitanko, Igor
AU - Nebolsin, Vladimir Evgenievich
PY - 2019
DA - 2019/11/30
PB - ANO Editorial Board of the journal Uspekhi Khimii
SP - 858-878
IS - 8
VL - 89
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors)
@article{2019_Novikov,
author = {Fedor Nikolaevich Novikov and Viktor Sergeevich Stroylov and Igor Svitanko and Vladimir Evgenievich Nebolsin},
title = {Molecular foundations of COVID-19 pathogenesis},
journal = {Russian Chemical Reviews},
year = {2019},
volume = {89},
publisher = {ANO Editorial Board of the journal Uspekhi Khimii},
month = {Nov},
url = {https://rcr.colab.ws/publications/10.1070/RCR4961},
number = {8},
pages = {858--878},
doi = {10.1070/RCR4961}
}
MLA
Cite this
MLA
Novikov, Fedor Nikolaevich, et al. “Molecular foundations of COVID-19 pathogenesis.” Russian Chemical Reviews, vol. 89, no. 8, Nov. 2019, pp. 858-878. https://rcr.colab.ws/publications/10.1070/RCR4961.
Views / Visits / Downloads
34 / 33 / 10

Keywords

antiviral drugs
coronavirus infection
COVID-19
molecular modelling
SARS-CoV-2

Abstract

The review summarizes the publications, available at the time it was written, addressing the chemical and biological processes that occur in the human body upon exposure to coronaviruses, in particular SARS-CoV-2. The mechanisms of viral particle entry into the cell, viral replication and impact on the immune system and on oxygen transport system are considered. The causes behind complications of the viral infection, such as vasculitis, thrombosis, cytokine storm and lung fibrosis, are discussed. The latest research in the field of small molecule medications to counteract the virus is surveyed. Molecular targets and possible vectors to exploit them are considered. The review is primarily written for specialists who want to understand the chains of activation, replication, action and inhibition of SARS-CoV-2. Due to the short period of such studies, the data on complexes of small molecule compounds with possible protein targets are not numerous, but they will be useful in the search and synthesis of new potentially effective drugs.

The bibliography includes 144 references.

References

1.
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su S., Wong G., Shi W., Liu J., Lai A.C., Zhou J., Liu W., Bi Y., Gao G.F.
Trends in Microbiology , 2016
2.
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman S., Netland J.
Nature Reviews Microbiology , 2009
3.
Coronavirus Pathogenesis
Weiss S.R., Leibowitz J.L.
Advances in Virus Research , 2011
4.
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., et. al.
The Lancet , 2020
5.
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou P., Yang X., Wang X., Hu B., Zhang L., Zhang W., Si H., Zhu Y., Li B., Huang C., Chen H., Chen J., Luo Y., Guo H., Jiang R., et. al.
Nature , 2020
6.
rcr_89_8_858bib6
Malik
Malays J. Pathol. , 2020
7.
rcr_89_8_858bib7
Khailany
Gene Rep. , 2020
8.
Virus-encoded proteinases and proteolytic processing in the Nidovirales
Ziebuhr J., Gorbalenya A.E., Snijder E.J.
Journal of General Virology , 2000
9.
The Molecular Biology of Coronaviruses
Masters P.S.
Advances in Virus Research , 2006
10.
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr A.R., Perlman S.
Methods in Molecular Biology , 2015
11.
SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
Knoops K., Kikkert M., Worm S.H., Zevenhoven-Dobbe J.C., van der Meer Y., Koster A.J., Mommaas A.M., Snijder E.J.
PLoS Biology , 2008
12.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M.
Nature , 2003
14.
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., Acton S.
Circulation Research , 2000
16.
rcr_89_8_858bib16
de Wilde
2018
18.
SARS-CoV, But not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entry
Huang I., Bosch B.J., Li W., Farzan M., Rottier P.M., Choe H.
Advances in Experimental Medicine and Biology , 2006
19.
SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells
Huang I., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., Vasilieva N., Dermody T.S., Harrison S.C., Dormitzer P.R., Farzan M., Rottier P.J., Choe H.
Journal of Biological Chemistry , 2006
20.
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Jin Y., Yang H., Ji W., Wu W., Chen S., Zhang W., Duan G.
Viruses , 2020
21.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., et. al.
The Lancet , 2020
22.
Severe acute respiratory syndrome
Peiris J.S., Guan Y., Yuen K.Y.
Nature Medicine , 2004
23.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S., Lau E.H., Wong J.Y., Xing X., Xiang N., Wu Y., Li C., Chen Q., et. al.
New England Journal of Medicine , 2020
24.
rcr_89_8_858bib24
Zhonghua Liu Xing Bing Xue Za Zhi , 2020
25.
Wang C., Xie J., Zhao L., Fei X., Zhang H., Tan Y., Zhou L., Liu Z., Ren Y., Yuan L., Zhang Y., Zhang J., Liang L., Chen X., Liu X., et. al.
2020
26.
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Chan J.F., Yuan S., Kok K., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., Tsoi H., Lo S.K., Chan K., Poon V.K., Chan W., et. al.
The Lancet , 2020
28.
Evidence for Gastrointestinal Infection of SARS-CoV-2
Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H.
Gastroenterology , 2020
29.
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng Y., Luo R., Wang K., Zhang M., Wang Z., Dong L., Li J., Yao Y., Ge S., Xu G.
Kidney International , 2020
30.
rcr_89_8_858bib31
Guan
Zhonghua Gan Zang Bing Za Zhi , 2020
31.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z.
JAMA - Journal of the American Medical Association , 2020
34.
rcr_89_8_858bib35
Liu
J. Virol. , 2010
35.
Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population
Keicho N., Itoyama S., Kashiwase K., Phi N.C., Long H.T., Ha L.D., Ban V.V., Hoa B.K., Hang N.T., Hijikata M., Sakurada S., Satake M., Tokunaga K., Sasazuki T., Quy T., et. al.
Human Immunology , 2009
36.
Epidemiological and Genetic Correlates of Severe Acute Respiratory Syndrome Coronavirus Infection in the Hospital with the Highest Nosocomial Infection Rate in Taiwan in 2003
Chen Y.A., Liang S., Shih Y., Chen C., Lee Y., Chang L., Jung S., Ho M., Liang K., Chen H., Chan Y., Chu D.
Journal of Clinical Microbiology , 2006
38.
Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection
Tu X., Chong W.P., Zhai Y., Zhang H., Zhang F., Wang S., Liu W., Wei M., Siu N.H., Yang H., Yang W., Cao W., Lau Y.L., He F., Zhou G., et. al.
Journal of Infection , 2015
40.
Profile of Specific Antibodies to the SARS-Associated Coronavirus
Li G., Chen X., Xu A.
New England Journal of Medicine , 2003
41.
SARS and MERS: recent insights into emerging coronaviruses
de Wit E., van Doremalen N., Falzarano D., Munster V.J.
Nature Reviews Microbiology , 2016
42.
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., et. al.
The Lancet Respiratory Medicine , 2020
43.
Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)
Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., Chen L., Li M., Liu Y., Wang G., Yuan Z., Feng Z., Wu Y., Chen Y.
medRxiv , 2020
44.
Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection
Fan Y., Huang Z., Li L., Wu M., Yu T., Koup R.A., Bailer R.T., Wu C.
Archives of Virology , 2009
45.
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Tang F., Quan Y., Xin Z., Wrammert J., Ma M., Lv H., Wang T., Yang H., Richardus J.H., Liu W., Cao W.
Journal of Immunology , 2011
46.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L.
The Lancet , 2020
47.
A new coronavirus associated with human respiratory disease in China
Wu F., Zhao S., Yu B., Chen Y., Wang W., Song Z., Hu Y., Tao Z., Tian J., Pei Y., Yuan M., Zhang Y., Dai F., Liu Y., Wang Q., et. al.
Nature , 2020
48.
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Mahallawi W.H., Khabour O.F., Zhang Q., Makhdoum H.M., Suliman B.A.
Cytokine , 2018
49.
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG C.K., LAM C.W., WU A.K., IP W.K., LEE N.L., CHAN I.H., LIT L.C., HUI D.S., CHAN M.H., CHUNG S.S., SUNG J.J.
Clinical and Experimental Immunology , 2004
51.
Multiple organ infection and the pathogenesis of SARS
Gu J., Gong E., Zhang B., Zheng J., Gao Z., Zhong Y., Zou W., Zhan J., Wang S., Xie Z., Zhuang H., Wu B., Zhong H., Shao H., Fang W., et. al.
Journal of Experimental Medicine , 2005
52.
rcr_89_8_858bib53
Yang
2020
54.
ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects
Keidar S., Strizevsky A., Raz A., Gamliel-Lazarovich A.
Nephrology Dialysis Transplantation , 2006
55.
How Could This Happen?
Allaerts W.
Acta Biotheoretica , 2020
56.
COVID-19, SARS and MERS: are they closely related?
Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E.
Clinical Microbiology and Infection , 2020
58.
The mercurial nature of neutrophils: still an enigma in ARDS?
Williams A.E., Chambers R.C.
American Journal of Physiology - Lung Cellular and Molecular Physiology , 2014
59.
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Cameron M.J., Bermejo-Martin J.F., Danesh A., Muller M.P., Kelvin D.J.
Virus Research , 2008
60.
rcr_89_8_858bib61
Min
Sci. Rep. , 2016
61.
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
Konig M.F., Powell M., Staedtke V., Bai R., Thomas D.L., Fischer N., Huq S., Khalafallah A.M., Koenecke A., Xiong R., Mensh B., Papadopoulos N., Kinzler K.W., Vogelstein B., Vogelstein J.T., et. al.
Journal of Clinical Investigation , 2020
62.
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Bardina S.V., Bunduc P., Tripathi S., Duehr J., Frere J.J., Brown J.A., Nachbagauer R., Foster G.A., Krysztof D., Tortorella D., Stramer S.L., García-Sastre A., Krammer F., Lim J.K.
Science , 2017
63.
Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors
Kuzmina N.A., Younan P., Gilchuk P., Santos R.I., Flyak A.I., Ilinykh P.A., Huang K., Lubaki N.M., Ramanathan P., Crowe J.E., Bukreyev A.
Cell Reports , 2018
64.
rcr_89_8_858bib65
65.
Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
Wang X., Li Y., O'Brien K.L., Madhi S.A., Widdowson M., Byass P., Omer S.B., Abbas Q., Ali A., Amu A., Azziz-Baumgartner E., Bassat Q., Abdullah Brooks W., Chaves S.S., Chung A., et. al.
The Lancet Global Health , 2020
66.
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Wang S., Tseng S., Yen C., Yang J., Tsao C., Shen C., Chen K., Liu F., Liu W., Chen Y.A., Huang J.C.
Biochemical and Biophysical Research Communications , 2014
67.
Incubation periods of acute respiratory viral infections: a systematic review
Lessler J., Reich N.G., Brookmeyer R., Perl T.M., Nelson K.E., Cummings D.A.
The Lancet Infectious Diseases , 2009
68.
Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
Niemeyer D., Zillinger T., Muth D., Zielecki F., Horvath G., Suliman T., Barchet W., Weber F., Drosten C., Müller M.A.
Journal of Virology , 2013
70.
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., Li Y., Hu Z., Zhong W., Wang M.
Cell Discovery , 2020
71.
MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
Menachery V.D., Schäfer A., Burnum-Johnson K.E., Mitchell H.D., Eisfeld A.J., Walters K.B., Nicora C.D., Purvine S.O., Casey C.P., Monroe M.E., Weitz K.K., Stratton K.G., Webb-Robertson B.M., Gralinski L.E., Metz T.O., et. al.
Proceedings of the National Academy of Sciences of the United States of America , 2018
72.
Dysregulation of immune response in patients with COVID-19 in Wuhan, China
Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.
Clinical Infectious Diseases , 2020
73.
rcr_89_8_858bib74
Yao
Zhonghua Bing Li Xue Za Zhi , 2020
74.
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Zhang W., Zhao Y., Zhang F., Wang Q., Li T., Liu Z., Wang J., Qin Y., Zhang X., Yan X., Zeng X., Zhang S.
Clinical Immunology , 2020
75.
rcr_89_8_858bib76
76.
rcr_89_8_858bib77
Munster
2020
77.
rcr_89_8_858bib78
Gong
2020
78.
Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease
Patel H.H., Patel H.R., Higgins J.M.
American Journal of Hematology , 2015
79.
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
Zhao J., Yang Y., Huang H., Li D., Gu D., Lu X., Zhang Z., Liu L., Liu T., Liu Y., He Y., Sun B., Wei M., Yang G., Wang X., et. al.
medRxiv , 2020
80.
Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
Guillon P., Clément M., Sébille V., Rivain J., Chou C., Ruvoën-Clouet N., Le Pendu J.
Glycobiology , 2008
81.
rcr_89_8_858bib82
Wang
2020
82.
Unavailability of CD147 leads to selective erythrocyte trapping in the spleen
Coste I., Gauchat J., Wilson A., Izui S., Jeannin P., Delneste Y., MacDonald H.R., Bonnefoy J., Renno T.
Blood , 2001
83.
Editorial: The mysteries of the spleen.
Dale David C
Journal of Leukocyte Biology , 2016
84.
Modern diagnosis and management of the porphyrias
85.
rcr_89_8_858bib86
Trier
Case Rep. Hematol. , 2013
86.
Sulovska L., Holub D., Zidova Z., Divoka M., Hajduch M., Mihal V., Vrbkova J., Horvathova M., Pospisilova D.
Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia , 2016
88.
An update of clinical management of acute intermittent porphyria
Pischik E., Kauppinen R.
Application of Clinical Genetics , 2015
89.
Lung pathology of fatal severe acute respiratory syndrome
Nicholls J.M., Poon L.L., Lee K.C., Ng W.F., Lai S.T., Leung C.Y., Chu C.M., Hui P.K., Mak K.L., Lim W., Yan K.W., Chan K.H., Tsang N.C., Guan Y., Yuen K.Y., et. al.
The Lancet , 2003
90.
Alveolar macrophages: plasticity in a tissue-specific context
Hussell T., Bell T.J.
Nature Reviews Immunology , 2014
91.
rcr_89_8_858bib92
92.
rcr_89_8_858bib93
93.
Evaluation of candidate vaccine approaches for MERS-CoV
Wang L., Shi W., Joyce M.G., Modjarrad K., Zhang Y., Leung K., Lees C.R., Zhou T., Yassine H.M., Kanekiyo M., Yang Z., Chen X., Becker M.M., Freeman M., Vogel L., et. al.
Nature Communications , 2015
94.
rcr_89_8_858bib95
95.
Déjà vu: Stimulating open drug discovery for SARS-CoV-2
Ekins S., Mottin M., Ramos P.R., Sousa B.K., Neves B.J., Foil D.H., Zorn K.M., Braga R.C., Coffee M., Southan C., Puhl A.C., Andrade C.H.
Drug Discovery Today , 2020
96.
rcr_89_8_858bib97
97.
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C., Abiona O., Graham B.S., McLellan J.S.
Science , 2020
98.
rcr_89_8_858bib99
99.
D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19
Shi Y., Zhang X., Mu K., Peng C., Zhu Z., Wang X., Yang Y., Xu Z., Zhu W.
Acta Pharmaceutica Sinica B , 2020
103.
Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach
Duarte R.R., Copertino Jr. D.C., Iñiguez L.P., Marston J.L., Nixon D.F., Powell T.R.
ChemRxiv , 2020
104.
Homology Modeling and Docking Studies of TMPRSS2 with Experimentally Known Inhibitors Camostat Mesylate, Nafamostat and Bromhexine Hydrochloride to Control SARS-Coronavirus-2
Sonawane K., Barale S.S., Dhanavade M.J., Waghmare S.R., Nadaf N.H., Kamble S.A., Mohammed A.A., Makandar A.M., Fandilolu P.M., Dound A.S., Naik N.M.
ChemRxiv , 2020
105.
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., Zheng M., Chen L., Li H.
Acta Pharmaceutica Sinica B , 2020
107.
Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
Chuck C., Chen C., Ke Z., Chi-Cheong Wan D., Chow H., Wong K.
European Journal of Medicinal Chemistry , 2013
108.
Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus
Mandadapu S.R., Weerawarna P.M., Prior A.M., Uy R.A., Aravapalli S., Alliston K.R., Lushington G.H., Kim Y., Hua D.H., Chang K., Groutas W.C.
Bioorganic and Medicinal Chemistry Letters , 2013
109.
Tahir ul Qamar M., Alqahtani S.M., Alamri M.A., Chen L.
Journal of Pharmaceutical Analysis , 2020
111.
rcr_89_8_858bib112
Yu
2020
112.
rcr_89_8_858bib113
Hall
2020
113.
Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC–MSE analysis
Zhang Z., Wu W., Hou J., Zhang L., Li F., Gao L., Wu X., Shi J., Zhang R., Long H., Lei M., Wu W., Guo D., Chen K., Hofmann L.A., et. al.
Journal of integrative medicine , 2020
114.
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
115.
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling
Lee H., Ren J., Pesavento R.P., Ojeda I., Rice A.J., Lv H., Kwon Y., Johnson M.E.
Bioorganic and Medicinal Chemistry , 2019
116.
The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
Lung J., Lin Y., Yang Y., Chou Y., Shu L., Cheng Y., Liu H.T., Wu C.
Journal of Medical Virology , 2020
119.
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
Ceribelli A., Motta F., De Santis M., Ansari A.A., Ridgway W.M., Gershwin M.E., Selmi C.
Journal of Autoimmunity , 2020
121.
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019
Liu T., Zhang J., Yang Y., Ma H., Li Z., Zhang J., Cheng J., Zhang X., Zhao Y., Xia Z., Zhang L., Wu G., Yi J.
medRxiv , 2020
122.
rcr_89_8_858bib123
Cantini
2020
123.
rcr_89_8_858bib124
Favalli
2020
124.
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
Kow C.S., Zaidi S.T., Hasan S.S.
American Journal of Cardiovascular Drugs , 2020
125.
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Sheahan T.P., Sims A.C., Zhou S., Graham R.L., Pruijssers A.J., Agostini M.L., Leist S.R., Schäfer A., Dinnon K.H., Stevens L.J., Chappell J.D., Lu X., Hughes T.M., George A.S., Hill C.S., et. al.
Science Translational Medicine , 2020
126.
rcr_89_8_858bib127
Abaturova
Zdorov’e Rebenka , 2020
128.
rcr_89_8_858bib129
Gentile
2019
130.
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
Fischer A., Sellner M., Neranjan S., Smieško M., Lill M.A.
International Journal of Molecular Sciences , 2020
131.
Stroylov Viktor Sergeevich, Rakitina Tatiana Vladimirovna, Novikov Fedor Nikolaevich, Stroganov Oleg Valentinovich, Chilov Ghermes Grigor'evich, Lipkin Aleksey Valer'evich
Mendeleev Communications , 2010
132.
Hit clustering can improve virtual fragment screening: CDK2 and PARP1 case studies
Zeifman A.A., Stroylov V.S., Novikov F.N., Stroganov O.V., Zakharenko A.L., Khodyreva S.N., Lavrik O.I., Chilov G.G.
Journal of Molecular Modeling , 2011
133.
Romashov Leonid Vladimirovich, Zeifman Alexey A, Zakharenko Alexandra Leonidovna, Novikov Fedor Nikolaevich, Stroylov Viktor Sergeevich, Stroganov Oleg Valentinovich, Chilov Ghermes Grigor'evich, Khodyreva Svetlana Nikolaevna, Lavrik Olga Ivanovna, Titov Ilya Yur'evich, Svitanko Igor
Mendeleev Communications , 2011
134.
Alchemical FEP Calculations of Ligand Conformer Focusing in Explicit Solvent
Zeifman A.A., Stroylov V.V., Novikov F.N., Stroganov O.V., Kulkov V., Chilov G.G.
Journal of Chemical Theory and Computation , 2013
135.
Zeifman Alexey A, Titov Ilya Yur'evich, Svitanko Igor, Rakitina Tatiana Vladimirovna, Lipkin Aleksey Valer'evich, Stroylov Viktor Sergeevich, Stroganov Oleg Valentinovich, Novikov Fedor Nikolaevich, Chilov Ghermes Grigor'evich
Mendeleev Communications , 2012
136.
rcr_89_8_858bib137
Medvedev
2020
139.
NMR screening and studies of target - Ligand interactions
Polshakov V.I., Batuev E.A., Mantsyzov A.B.
Russian Chemical Reviews , 2019
140.
Marjewski Alexander Aleksandrovich, Medvedev Michael G, Gerasimov Igor S, Panova Maria Vyacheslavovna, Perdew John P, Lyssenko Konstantin Alexandrovich, Dmitrienko Artem Olegovich
Mendeleev Communications , 2018
142.
rcr_89_8_858bib143
Pinto
2020
143.
rcr_89_8_858bib144